Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
MuReva Phototherapy
AddedMay 5, 2026
UpdatedMay 31, 2026
MuReva Phototherapy

MuReva Phototherapy

Medical device company developing photobiomodulation therapy for oral mucositis

HQ
Brecksville, OH, US
Founded
2018
Overview
Compare
Employees
News
Website

MuReva Phototherapy develops LED-based photobiomodulation therapy devices to prevent and treat radiation and chemotherapy-induced oral mucositis in cancer patients. The company's MuReva OM system uses novel lightguide technology to deliver controlled light dosages to all oral mucositis-susceptible tissues simultaneously.

MuReva was founded in 2018 as a spin-off from Lumitex, a leader in fiber-optic lighting technologies. The company is based in Brecksville, Ohio with an additional office in San Diego, California, and has received FDA Breakthrough Device Designation for its technology.

MuReva Phototherapy - Similar Companies

Lumitex logo

Lumitex

Lumeda logo

Lumeda

lumedainc.com

Photopharmics logo

Photopharmics

photopharmics.com

Keraderm logo

Keraderm

LumiThera logo

LumiThera

lumithera.com

Photometics logo

Photometics

PhotoThera logo

PhotoThera

Photetica logo

Photetica

NeoLight logo

NeoLight

theneolight.com

Lumed Science logo

Lumed Science

Stimusil logo

Stimusil

stimusil.com

SkinCure Oncology logo

SkinCure Oncology

Civatech Oncology logo

Civatech Oncology

Novocure logo

Novocure

novocure.com

Light Line Medical logo

Light Line Medical

Photonpharma logo

Photonpharma

photonpharma.net

MuReva Phototherapy - Quick Facts

Who are MuReva Phototherapy's competitors?

Companies similar to MuReva Phototherapy include Lumeda, Photopharmics, Keraderm and LumiThera.

When was MuReva Phototherapy founded?

MuReva Phototherapy was founded in 2018.

Where is MuReva Phototherapy's headquarters located?

MuReva Phototherapy's headquarters is located in Brecksville, OH, US.

MuReva Phototherapy - Classification

Technology
  • Medical Device
Geographic Exposure
  • Americas United States
Revenue
  • Recurring
Customer
  • Institutions
Main Product
  • Medical Device
Tags
  • Cancer Treatment
  • Medical Device